4 years of historical data (2021–2024) · Healthcare · Biotechnology
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
BlackRock Technology and Private Equity Term Trust trades at 38.6x earnings, 50% above its 5-year average of 25.6x, sitting at the 50th percentile of its historical range. Compared to the Healthcare sector median P/E of 23.3x, the stock trades at a premium of 65%. On a free-cash-flow basis, the stock trades at 2.8x P/FCF, 55% below the 5-year average of 6.1x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $765M | $1.6B | $1.6B | $1.6B | $3.6B |
| Enterprise Value | $765M | $1.6B | $1.6B | $1.6B | $3.6B |
| P/E Ratio → | 38.56 | 43.76 | 7.48 | — | — |
| P/S Ratio | 18.80 | 39.47 | 7.34 | — | — |
| P/B Ratio | 0.79 | 0.90 | 0.78 | 0.81 | 0.91 |
| P/FCF | 2.76 | 5.79 | 7.31 | 5.26 | — |
| P/OCF | 2.76 | 5.79 | 7.31 | 5.26 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
BlackRock Technology and Private Equity Term Trust's enterprise value stands at 21.4x EBITDA, 18% below its 5-year average of 26.2x. The Healthcare sector median is 13.6x, placing the stock at a 58% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | 39.47 | 7.34 | — | — |
| EV / EBITDA | 21.43 | 44.99 | 7.48 | — | — |
| EV / EBIT | 21.43 | — | — | — | — |
| EV / FCF | — | 5.79 | 7.31 | 5.26 | — |
Margins and return-on-capital ratios measuring operating efficiency
BlackRock Technology and Private Equity Term Trust earns an operating margin of 87.7%. Operating margins have compressed from 100.2% to 87.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 1.9% is modest. ROIC of 1.4% represents below-average returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 87.7% | 87.7% | 98.1% | 100.2% | 100.1% |
| Net Profit Margin | 87.7% | 87.7% | 98.1% | 100.2% | 100.1% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | 1.9% | 1.9% | 10.4% | -55.1% | -16.1% |
| ROA | 1.8% | 1.8% | 10.3% | -54.5% | -15.9% |
| ROIC | 1.4% | 1.4% | 7.8% | -41.4% | — |
| ROCE | 1.8% | 1.8% | 10.3% | -54.5% | — |
Solvency and debt-coverage ratios — lower is generally safer
Interest coverage of 2313.2x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | 0.00 | -0.00 | -0.00 | -0.00 |
| Net Debt / EBITDA | — | 0.00 | -0.00 | — | — |
| Debt / FCF | — | 0.00 | -0.00 | -0.00 | — |
| Interest Coverage | 2313.25 | 2313.25 | 141140.11 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| Cash Ratio | — | — | — | — | — |
| Asset Turnover | — | 0.02 | 0.10 | -0.80 | -0.16 |
| Inventory Turnover | — | — | — | — | — |
| Days Sales Outstanding | — | 0.60 | 0.56 | -0.92 | -3.65 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
BlackRock Technology and Private Equity Term Trust returns 25.1% to shareholders annually — split between a 13.1% dividend yield and 12.1% buyback yield. The payout ratio exceeds 100% at 517.4%, meaning the company is paying out more than it earns — this level is unsustainable long-term without earnings recovery. The earnings yield of 2.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | 13.1% | 11.5% | 11.1% | 14.4% | 4.5% |
| Payout Ratio | 517.4% | 517.4% | 83.2% | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | 2.6% | 2.3% | 13.4% | — | — |
| FCF Yield | 36.2% | 17.3% | 13.7% | 19.0% | — |
| Buyback Yield | 12.1% | 5.8% | 2.6% | 4.6% | 1.7% |
| Total Shareholder Yield | 25.1% | 17.3% | 13.7% | 19.0% | 6.2% |
| Shares Outstanding | — | $216M | $216M | $240M | $248M |
Compare BTX with 7 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $765M | 38.6 | 21.4 | 2.8 | 100.0% | 87.7% | 1.9% | 1.4% | — | |
| $7B | 26.6 | 9.9 | 2.8 | — | 65.6% | 7.7% | 6.7% | 5.7 | |
| $4B | -918.6 | 309.3 | 51.3 | 93.4% | -13.5% | -0.5% | -2.3% | 0.6 | |
| $2B | 6.7 | 5.4 | 8.5 | 72.3% | 38.5% | 29.1% | 16.8% | — | |
| $321M | -15.8 | — | — | 99.3% | -140.3% | -16.2% | -37.6% | — | |
| $305M | -15.5 | — | — | 99.3% | -140.3% | -16.2% | -37.6% | — | |
| $106M | -0.3 | — | — | 100.0% | -6062.8% | -115.3% | -86.2% | — | |
| $30M | -0.0 | — | — | — | — | — | — | — | |
| Healthcare Median | — | 23.3 | 13.6 | 18.1 | 66.0% | -6.6% | -36.9% | -13.6% | 3.0 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 4 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how BTX stacks up against sector leader Royalty Pharma plc.
Start ComparisonBlackRock Technology and Private Equity Term Trust's current P/E ratio is 38.6x. The historical average is 25.6x. This places it at the 50th percentile of its historical range.
BlackRock Technology and Private Equity Term Trust's current EV/EBITDA is 21.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 26.2x.
BlackRock Technology and Private Equity Term Trust's return on equity (ROE) is 1.9%. The historical average is -14.7%.
Based on historical data, BlackRock Technology and Private Equity Term Trust is trading at a P/E of 38.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
BlackRock Technology and Private Equity Term Trust's current dividend yield is 13.05% with a payout ratio of 517.4%.
BlackRock Technology and Private Equity Term Trust has 100.0% gross margin and 87.7% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.